Development of human bispecific antibodies against CD20/CD55 or CD20/CD59 for the treatment of Burkitt lymphomaP. Macor,E. Secco,N. Mezzaroba,L. De Maso,P. Durigutto,T. Gaiotto,C. Garrovo,F. Biffi,S. Zorzet,D. Sblattero,F. TedescoMOLECULAR IMMUNOLOGY(2010)引用 1|浏览13暂无评分关键词Bispecific AntibodiesAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要